SecBot SecBot
SECBOTREPLAY Home › Report › IOVA

IOVA · Iovance Biotherapeutics granted inducement stock options covering…

Iovance Biotherapeutics, Inc. · PRESS-RELEASE filed May 22, 2026 at 17:15 ET

At the news

NEUTRALIMPACT 2/10

PRESS-RELEASE filed May 22, 2026 at 17:15 ET

Iovance Biotherapeutics granted inducement stock options covering 93,340 shares to 13 new non-executive employees under its 2021 Inducement Plan. The options have an exercise price of $3.70 and vest over three years. This is a routine equity grant for new hires, not a material financial event.

  • 93,340 shares of common stock granted as inducement stock options to 13 new non-executive employees.
  • Exercise price of $3.70, equal to the closing price on the grant date (May 21, 2026).
  • Options vest over three years: one-third on first anniversary, remainder in quarterly installments.
  • Granted under the Amended and Restated 2021 Inducement Plan per Nasdaq Listing Rule 5635(c)(4).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access